EMA Authorised: Alli (previously Orlistat GSK) (orlistat) — Haleon Ireland Dungarvan Limited

View source ↗

Summary

The EMA authorised Alli (orlistat) for obesity in the European Union. The marketing authorization holder is Haleon Ireland Dungarvan Limited, with a decision da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ALLI (orlistat)

Snippet

Status: Authorised. Therapeutic area: Obesity. MAH: Haleon Ireland Dungarvan Limited. Decision date: 04/12/2024